Literature DB >> 3804904

Ciprofloxacin for soft tissue infections.

M J Wood, M N Logan.   

Abstract

Twenty-one patients with cellulitis or other bacterial soft-tissue infections were treated with oral ciprofloxacin. One patient developed nausea and vomiting and was withdrawn from the study, but 19 of the other 20 were clinically cured or improved. Only nine of the original 18 bacterial isolates were completely eradicated, however, the majority of the failures being staphylococci or streptococci. There was no evidence from disc sensitivity testing of resistance developing during treatment. No serious toxicity was seen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804904     DOI: 10.1093/jac/18.supplement_d.159

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.

Authors:  J Schwartz; L Jauregui; J Lettieri; K Bachmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 2.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

3.  Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.

Authors:  D M Bamberger; M T Fields; B L Herndon
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 5.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 6.  The use of oral fluoroquinolones in nursing home patients.

Authors:  T M File; J S Tan
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 7.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.